Skip to content

Watch the on-demand webinar 

Familial  hypercholesterolemia: How an early genetic pediatric screening can guide treatment

In this webinar, Prof. Albert Wiegman (MD, PhD), paediatric cardiologist at Amsterdam UMC, talks about how early paediatric screening and genetic testing can guide detection and treatment of familial hypercholesterolemia (FH).

Currently, FH is diagnosed later in life at an median age of 44. In the webinar, Prof. Wiegman details how early cholesterol screening and genetic testing in children can improve patient outcomes and provide a cost-effective treatment strategy.